Neesha Rockwood
Neesha Rockwood
Senior Lecturer in Microbiology, University of Colombo
Verified email at micro.cmb.ac.lk
Title
Cited by
Cited by
Year
Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
N Rockwood, S Mandalia, M Bower, B Gazzard, M Nelson
Aids 25 (13), 1671-1673, 2011
892011
Chronic hepatitis E as a cause for cryptogenic cirrhosis in HIV
GKJ Singh, S Ijaz, N Rockwood, SP Farnworth, E Devitt, M Atkins, ...
Journal of Infection 66 (1), 103-106, 2013
842013
Assessment of treatment response in tuberculosis
N Rockwood, E du Bruyn, T Morris, RJ Wilkinson
Expert review of respiratory medicine 10 (6), 643-654, 2016
492016
Concentration-dependent antagonism and culture conversion in pulmonary tuberculosis
N Rockwood, JG Pasipanodya, P Denti, F Sirgel, M Lesosky, T Gumbo, ...
Clinical Infectious Diseases 64 (10), 1350-1359, 2017
382017
Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study
K Zürcher, M Ballif, L Fenner, S Borrell, PM Keller, J Gnokoro, O Marcy, ...
The Lancet Infectious Diseases 19 (3), 298-307, 2019
352019
A systematic review on the effect of HIV infection on the pharmacokinetics of first-line tuberculosis drugs
A Daskapan, LR Idrus, MJ Postma, B Wilffert, JGW Kosterink, Y Stienstra, ...
Clinical pharmacokinetics 58 (6), 747-766, 2019
342019
Mycobacterium tuberculosis induction of heme oxygenase-1 expression is dependent on oxidative stress and reflects treatment outcomes
N Rockwood, DL Costa, EP Amaral, E Du Bruyn, A Kubler, L Gil-Santana, ...
Frontiers in immunology 8, 542, 2017
292017
High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis
E Pietersen, J Peter, E Streicher, F Sirgel, N Rockwood, B Mastrapa, ...
PLoS one 10 (4), e0123655, 2015
212015
Risk factors for acquired rifamycin and isoniazid resistance: a systematic review and meta-analysis
N Rockwood, LH Abdullahi, RJ Wilkinson, G Meintjes
PloS one 10 (9), e0139017, 2015
202015
HIV-1 coinfection does not reduce exposure to rifampin, isoniazid, and pyrazinamide in South African tuberculosis outpatients
N Rockwood, G Meintjes, M Chirehwa, L Wiesner, H McIlleron, ...
Antimicrobial agents and chemotherapy 60 (10), 6050-6059, 2016
192016
Immune compromise in HIV-1/HTLV-1 coinfection with paradoxical resolution of CD4 lymphocytosis during antiretroviral therapy: a case report
N Rockwood, L Cook, H Kagdi, S Basnayake, CRM Bangham, ...
Medicine 94 (50), 2015
142015
Pancreatic insufficiency in patients with HIV infection: role of didanosine questioned
TCS Martin, A Scourfield, N Rockwood, NK Martin, N Patel, M Nelson, ...
HIV medicine 14 (3), 161-166, 2013
122013
Low frequency of acquired isoniazid and rifampicin resistance in rifampicin-susceptible pulmonary tuberculosis in a setting of high HIV-1 infection and tuberculosis coprevalence
N Rockwood, F Sirgel, E Streicher, R Warren, G Meintjes, RJ Wilkinson
The Journal of infectious diseases 216 (6), 632-640, 2017
102017
Syphilis the great pretender: when is cancer not cancer?
N Rockwood, N Nwokolo
Sexually transmitted infections 94 (3), 192-193, 2018
82018
Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice daily in patients on suppressive antiretroviral therapy
L Waters, A Jackson, L Else, N Rockwood, S Newell, D Back, M Nelson, ...
Antivir Ther 20 (2), 157-63, 2015
82015
Global access of rifabutin for the treatment of tuberculosis–why should we prioritize this?
N Rockwood, M Cerrone, M Barber, AM Hill, AL Pozniak
Journal of the International AIDS Society 22 (7), e25333, 2019
72019
International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden …
K Zürcher, M Ballif, L Fenner, S Borrell, PM Keller, J Gnokoro, O Marcy, ...
Lancet Infect Dis 19 (3), 298-307, 2019
72019
Utility of Second-Generation Line Probe Assay (Hain MTBDRplus) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response
N Rockwood, J Wojno, Y Ghebrekristos, MP Nicol, G Meintjes, ...
Journal of clinical microbiology 55 (5), 1508-1515, 2017
62017
A comparative analysis of risk factors associated with efavirenz, darunavir/ritonavir, lopinavir/ritonavir, atazanavir/ritonavir and renal impairment
N Rockwood, MR Nelson, S Mandalia, B Gazzard
International AIDS Society, 2011
62011
Understanding and intervening in HIV-associated tuberculosis
N Rockwood, RJ Wilkinson
Clinical Medicine 15 (Suppl 6), s43-s49, 2015
52015
The system can't perform the operation now. Try again later.
Articles 1–20